The pathological changes observed in AD are complex, involving the aggregation of amyloid-beta (Aβ), hyperphosphorylation of tau protein, cholinergic system dysfunction, neuroinflammation and oxidative stress [2–5]. Here, MAPT is linked to Alzheimer disease.